In addition, biallelic mutations in several MSI CRC cell lines and the occurrence of mutations in pre-neoplastic lesions provide strong evidence for a likely contribution of UPF3A mutations to MSI tumorigenesis. The gene discussed is UPF3A; the disease is colorectal carcinoma.